Chandler D. Robinson owns 2.50% of Monopar Therapeutics
167,539 shares as of the September 30, 2026 filing, worth $11.6M at the latest close.
MNPR · $465M market cap · Founder-ledGet an email when Chandler D. Robinson’s stake moves.
Free.
The stake
2.50%
worth $11.6M at the latest close
Stake rank
#1,616
by dollar value of the stake
Last sale
390 days ago
Sep 24, 2025
Last buy
2,497 days ago
Dec 18, 2019 · $1M
Chandler D. Robinson owns 2.50% of Monopar Therapeutics: 167,539 of 6,712,172 shares, worth about $11.6M at the 2026-10-16 close. The stake has moved from 47.84% in 2018 to 2.50% on 2026-09-30, across 3 sales and 1 purchase that moved it since 2016. The last trade that moved it was a discretionary sale of $35M on 2025-09-24.
How the stake is held
as of the Sep 30, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Sep 30, 2026 · Form 4 ↗
HELD DIRECTLY
104,724
62.5%
HELD INDIRECTLY · Indirect, per the filing’s footnote
62,815
37.5%
THE STAKE
167,539
2.50%